2018 - 2026
Need a report that reflects how COVID-19 has impacted this market and its growth?
The In Vitro Fertilization Market was valued at approximately USD 685 million in 2020 and is expected to witness a revenue of USD 1,102 million in 2026, with a CAGR of 8.2% over the forecast period.
The impact on COVID-19 pandemic on the studied market is anticipated to be significant as most of the countries across globe have been adopted their own strategies to diminish and eliminate the spread of coronavirus. For instance, the healthcare sectors offering infertility treatments were in inline with the recommendations provided by the WHO. Scientific societies, such as the European Society for Human Reproduction and Embryology and American Society for Reproductive Medicine, have provided recommendations and guidance to overcome and flatten the growing curve of infection in patients who undergo IVF treatments. According to a research article titled “Suspension of fertility treatments during COVID-19 has mental health impacts”, published on Sep 2020, the American Society of Reproductive Medicine and the Canadian Fertility and Andrology Society announced their recommendations to immediately and indefinitely suspend all in-person fertility treatments in the United States and Canada due to COVID-19 from March 17, 2020. As a result, 86 percent of couples amidst treatment reported that treatment suspensions had a negative impact on their mental health and 52 percent reported clinically significant depression symptoms. Also, the recommendations included suspending initiation of new treatments and an alternative freeze-all protocol in cases where couples have already undergone human chorionic gonadotrophin triggering and consideration of cryopreservation of gametes for cases of urgent fertility preservation. Thus, the COVID-19 pandemic is expected to have tremendous impact on the growth of the studied market.
The increasing awareness on advanced In Vitro Fertilization(IVF) techniques, rising success rates of IVF, and disorders due to the delayed onset of pregnancy have stimulated the demand for in vitro fertilization techniques across the world.
The proportion of women who are intentionally delaying pregnancies beyond the age of 35 years has been increasing in the past few years. Delay in pregnancy is a major cause of infertility. Delayed pregnancies, in many cases, lead to pregnancy-associated complications and an increased chance of infertility. According to the Center for Disease Control and Prevention (CDC), about 10 percent of women (6.1 million) in United States aged between 15 -44 have difficulty in getting pregnant or staying pregnant each year. Also, a study by the Hebrew University of Jerusalem revealed that sperm counts for men have more than halved over the last 40 years. As per the UN World Fertility report 2019, the rapid fertility declines were observed in 77 countries globally and areas where adolescent fertility declined by more than 50 per cent between 1990-1995 and 2015-2020.
Furthermore, the growing focus on research and strategic alliances by the key players is driving the market growth. For instance,iIn Jul 2019, Vitrolife signed a collaboration agreement with Prime Tech to develop and exclusively market the Piezo technique for improved Intracytoplasmic sperm injection (ICSI) procedure in human IVF globally except for Japan, Thailand and Malaysia
Moreover, the increasing trend of delayed pregnancy is contributing to the higher adoption of IVF techniques. However, the complications associated with the IVF technique and socio-ethical issues involved are expected to restrict the growth of the market studied, over the forecast period.
Scope of the Report
In Vitro Fertilization is an Assistive Reproductive Technology, which involves the process of fertilization by retrieving eggs from the woman's ovaries and fertilizing them with sperm outside the body, under a laboratory environment. The in vitro fertilization market is segmented by products, end-user, and geography. By products, the market is segmented into reagents, and instruments (imaging systems, incubators, cryosystems, IVF cabinet, ovum aspiration pump, sperm separation systems, micromanipulator systems, and other instruments). By end-user, the market is segmented into fertility clinics, hospitals, and other end users. By Geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The report offers the value (in USD million) for the above segments.
|Other End Users|
Key Market Trends
The Sperm Separation Systems Segment is Estimated to Hold the Largest Share in Terms of Revenue Generated over the Forecast Period
Sperm Separation Systems are used in most Assisted reproductive technology (ART) such as in In vitro fertilization (IVF) and artificial insemination. These systems are crucial for ARTs as they provide purified samples for further procedures. Furthermore, the rising focus of companies on developing novel devices for use in assisted reproductive technology (ART) procedures conducted by fertility clinics and obstetrician-gynecologist (OB/GYN) practices is driving the market growth. For instance, in March 2018, DxNow, Inc., received US FDA 510(k) clearance of its ZyMōt ICSI and ZyMōt Multi Sperm Separation Devices. The devices are used in the separation and preparation of highly-motile sperm with normal morphology and thus aid in assisted reproductive technology procedures. The ZyMōt Multi (provided with 850µl and 3ml collection chambers) has an inlet port that communicates with the lower sample chamber. The sample chambers are separated by a microporous filter. Untreated semen is added through the inlet port and after a period of time, the separated sperm are collected from the upper chamber through the outlet port.
Healthier sperm produce outcomes, such as improved progressive motility, a higher proportion of normal morphology, increased fertilization rates, and higher euploidy and pregnancy rates. The improved outcome associated with these devices may fuel its demand in the future.
Additionally, as per the research article published in BioRXiV, 2020, a new microchamber-based microfluidics platform was studied to separate only the progressively motile sperm directly from a raw semen sample in a short period of time of approximately 10 minutes. Hence owing to the recent advancements and novel product launches, the market is expected to grow at a healthy CAGR over the forecast period.
To understand key trends, Download Sample Report
North America is Holds a Significant Share in the Market and Expected to do Same over the Forecast Period
The North American Region is expected to witness significant growth in the In Vitro Fertilization market owing to the rising prevalence of associated conditions such as Polycystic Ovary Syndrome (PCOS). A constant rise in the incidence of infertility in both sexes is projected to drive the studied market in the region.
As per the SingleCare online Survey, conducted in October 2020, 20% of the respondents received In Vitro fertilization (IVF) in the United States. Additionally, 19% of the respondents reported polycystic ovarian syndrome(PCOS), and 25% reported unknown reasons for infertility. Thus, the high incidence of infertility is driving the studied market growth.
Newly launched fertility centers and reimbursement policies for infertility treatment are among the factors driving the demand for infertility treatment devices in the region. For instance, as of August 2020, fertility insurance coverage laws had been passed in 19 states of the United States, 13 of those laws include IVF coverage, and 10 states have fertility preservation laws for iatrogenic (medically-induced) infertility. This will increase the treatment rate thereby increasing the demand for fertility treatment devices. Additionally, in September 2020, Inception Fertility (Inception) launched of a new network of clinics in Atlanta and Georgia named as Pathways Fertility (Pathways) to shift the paradigm of the fertility market and enhance the patient experience. This will boost the treatment rate among the infertile population thereby positively influencing the regional growth.
Furthermore, the presence of well-established market players and newly launched products and increasing product approval also pave a way for market growth. In 2018, the Cooper Companies Acquired the LifeGlobal Group which is one of the leading providers of in-vitro fertilization (IVF) devices to expand its Fertility Solutions Portfolio. Thus, owing to the huge base of the patient population, increasing product launch, presence of strong foothold of market players, and rising government support for the fertility treatment the market that is likely to grow at healthy CAGR
To understand geography trends, Download Sample Report
The In Vitro Fertilization Market is moderately competitive with key players dominating the market globally. However, several local players have control over a significant share of the market, in spite of the presence of major global players, such as Merck KGaA, Thermo Fisher Scientific Inc., Vitrolife AB, Nikon Corporation, and Fujifilm Holding Corporation. The key players have been evolving through strategies such as acquisitions and partnerships along with new product launches to sustain in the global market. For instance, in May 2019, Hamilton Thorne Ltd. launched the Dynamic Targeting System (DTS) option for its next-generation LYKOS laser system for the In-vitro Fertilization clinical market. Additionally, in August 2019, Hamilton Thorne, Inc., acquired Planer Limited, one of the leading manufacturers of incubators, control rate freezers, and lab monitoring systems for the Assisted Reproductive Technology (ART) and cell biology markets worldwide and a provider of related services in the United Kingdom.
- In January 2021, Royal Philips and Merck KGaA entered into a multi-year partnership to develop digital solutions for personalized fertility treatments.
- In January 2020, Merck KGaA received the European Commission (EC) Marketing Authorization (MA) for its new GONAL-f (follitropin alfa) 150 IU pen, for the patients from the beginning to the end of their fertility stimulation cycle, when lower doses are required.
Table of Contents
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Success Rate of IVF Technology
4.2.2 Increasing Awareness about IVF Technology
4.2.3 Delayed Onset of Pregnancies
4.3 Market Restraints
4.3.1 Complications Associated with In Vitro Fertilization
4.3.2 Social Stigma, Ethical, and Legal Issues Associated with In Vitro Fertilization
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Product
5.1.1 By Reagent
5.1.2 By Instrument
22.214.171.124 Imaging Systems
126.96.36.199 IVF Cabinet
188.8.131.52 Ovum Aspiration Pump
184.108.40.206 Sperm Separation Systems
220.127.116.11 Micromanipulator Systems
18.104.22.168 Other Instruments
5.2 By End-User
5.2.1 Fertility Clinics
5.2.3 Other End Users
5.3 By Geography
5.3.1 North America
22.214.171.124 United States
126.96.36.199 United Kingdom
188.8.131.52 Rest of Europe
184.108.40.206 South Korea
220.127.116.11 Rest of Asia-Pacific
5.3.4 Middle East and Africa
18.104.22.168 South Africa
22.214.171.124 Rest of Middle East and Africa
5.3.5 South America
126.96.36.199 Rest of South America
6. COMPETITIVE LANDSCAPE
*List Not Exhaustive
6.1 Company Profiles
6.1.1 Cook Group Incorporated
6.1.2 CooperSurgical Inc.
6.1.3 Fujifilm Holdings Corporation
6.1.4 Genea Biomedx Pty Ltd
6.1.5 Hamilton Thorne Ltd
6.1.6 Merck KGaA
6.1.7 Nidacon International AB
6.1.8 Nikon Corporation
6.1.9 Thermo Fisher Scientific Inc.
6.1.10 Vitrolife AB
6.1.11 INVO Bioscience
6.1.12 Esco Micro Pte, Ltd
6.1.13 IVFtech APS
6.1.14 Oxford Gene Technology
6.1.15 Kitazato Corporation
6.1.16 Rocket Medical plc
6.1.17 Ovascience, Inc.
6.1.18 Bayer AG
6.1.19 Progyny, Inc.
6.1.20 Boston IVF
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The Global In Vitro Fertilization Market market is studied from 2018 - 2026.
What is the growth rate of Global In Vitro Fertilization Market?
The Global In Vitro Fertilization Market is growing at a CAGR of 8.2% over the next 5 years.
What is Global In Vitro Fertilization Market size in 2018?
The Global In Vitro Fertilization Market is valued at 685 Million USD in 2018.
What is Global In Vitro Fertilization Market size in 2026?
The Global In Vitro Fertilization Market is valued at 1102 Million USD in 2026.
Which region has highest growth rate in Global In Vitro Fertilization Market?
Asia Pacific is growing at the highest CAGR over 2021- 2026.
Which region has largest share in Global In Vitro Fertilization Market?
North America holds highest share in 2020.
Who are the key players in Global In Vitro Fertilization Market?
- Thermo Fisher Scientific Inc.
- Vitrolife AB
- Nikon Corporation
- Fujifilm Corporation
- Merck KGaA
Are the major companies operating in Global In Vitro Fertilization Market.